X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Cell-Energy Activity In Organs, Tissues By New MRI Method

    Cell-Energy Activity In Organs, Tissues By New MRI Method

    GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing

    Australia Sepsis Study To Aid In New Antibiotic Discovery

    FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

    COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

    Regulatory Actions Needed For Gaps In Cancer Drug Info

    A Fund Boost For World-First Nervous System Transplant Study

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Cell-Energy Activity In Organs, Tissues By New MRI Method

    Cell-Energy Activity In Organs, Tissues By New MRI Method

    GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing

    Australia Sepsis Study To Aid In New Antibiotic Discovery

    FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

    COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

    Regulatory Actions Needed For Gaps In Cancer Drug Info

    A Fund Boost For World-First Nervous System Transplant Study

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Seamlessness In Patient Engagement Through eConsent Trial

Content Team by Content Team
5th April 2023
in News
TrakCel and WindMIL Therapeutics partner on cell therapy supply chain management and orchestration platform

For the very first time, drug research participants can go on to give digital consent when it comes to their participation. This will take place in the first study that will happen in all Dutch general practitioner practises partnered by the research from the Maastricht UMC+. Under this study, a lot of drugs pertaining to COVID-19 are being taken into consideration.

The digital consent when it comes to research participation, which is also known as eConsent, has been made possible since May last year because of the new legislation. Although it is now being applied for the first time in a study following the nod from the Medical Ethics Committee of the Maastricht UMC+. The METC happens to be an independent group that keeps track of whether medical scientific research that involves humans meets all the requirements.

It is well to note that traditionally, participants when it comes to medical and scientific research had to give consent via a paper form that had a wet signature. However, in case if it was to be sent through post, the delay would occur. This went on to make the countrywide study very difficult for patients who were acutely ill.

For instance, if someone had to pay a visit to a general practitioner with a serious illness, in this scenario, the patient or the practitioner would not choose to treat the illness that is within the scope of the study since it would be many days before the beginning of the treatment. Through eConsent, the delay is reduced significantly.

This is the scenario with COVID-19 as well. If a patient with symptoms pays a visit to the general practitioner, what is desired is a rapid start of treatment. At the same time, studying the drugs against a new condition is pretty important. Therefore, it made sense to put into effect eConsent well within the PLATFORM-COVID research. In the said case, the patients will have contact with the researchers from Maastricht by way of a video call for up to 24 hours or one day after the general practitioner visit when it comes to an explanation. In this conversation, the patient can go ahead with his consent through a digital system. Post this, the researchers will ensure that the patient goes on to receive the right medication that’s delivered to their home the very next day.

Significantly, from May this year, all the Dutch GPs can go on to enrol patients in PLATFORM-COVID research. This happens to be the first study that will take place across all the GP practises, as it happens to be a part of the consortium, which is indeed a national initiative when it comes to enabling large-scale research across the general practises in the Netherlands.

The fact remains that the technology behind eConsent has to be reliable as well as safe, and overall, it should be suitable for the study. It is well to be noted that the technology of Your Research plays a key role when it comes to this study because it goes on to support the process of the entire research, right from patient interaction through the app.

Notably, this app helps patients with data, e-Consent, appointments via video call, and also specific information.

This enables the research team to easily coordinate the process in a very amicable environment, as well as monitor it precisely.

Previous Post

Australia Sepsis Study To Aid In New Antibiotic Discovery

Next Post

Cell-Energy Activity In Organs, Tissues By New MRI Method

Related Posts

Cell-Energy Activity In Organs, Tissues By New MRI Method
News

Cell-Energy Activity In Organs, Tissues By New MRI Method

5th April 2023
GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing
Drug Development

Australia Sepsis Study To Aid In New Antibiotic Discovery

5th April 2023
FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19
News

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

5th April 2023
AI Assesses The Enzyme Functions Finer Than Leading Tools
IPR Data Management

AI Assesses The Enzyme Functions Finer Than Leading Tools

4th April 2023
FDA Approvals

Regulatory Actions Needed For Gaps In Cancer Drug Info

4th April 2023
News

A Fund Boost For World-First Nervous System Transplant Study

4th April 2023
Next Post
Cell-Energy Activity In Organs, Tissues By New MRI Method

Cell-Energy Activity In Organs, Tissues By New MRI Method

Latest News

Cell-Energy Activity In Organs, Tissues By New MRI Method
News

Cell-Energy Activity In Organs, Tissues By New MRI Method

5th April 2023
TrakCel and WindMIL Therapeutics partner on cell therapy supply chain management and orchestration platform
News

Seamlessness In Patient Engagement Through eConsent Trial

5th April 2023
GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing
Drug Development

Australia Sepsis Study To Aid In New Antibiotic Discovery

5th April 2023
FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19
News

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

5th April 2023
AI Assesses The Enzyme Functions Finer Than Leading Tools
IPR Data Management

AI Assesses The Enzyme Functions Finer Than Leading Tools

4th April 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In